The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
MagnetisMM-6: An open-label, multicenter, randomized phase 3 study of elranatamab + daratumumab + lenalidomide (EDR) versus daratumumab + lenalidomide + dexamethasone (DRd) in transplant ineligible (TI) patients with newly diagnosed multiple myeloma (NDMM).
 
Sebastian Grosicki
No Relationships to Disclose
 
Su-Peng Yeh
Honoraria - Abbvie; Amgen; Astellas Pharma; Bayer; Bristol-Myers Squibb; Janssen; Novartis; Sanofi; Takeda
Consulting or Advisory Role - Abbvie; Chugai Pharma; Janssen; Novartis; Pfizer; Sanofi
 
Jeffrey S.Y. Huang
No Relationships to Disclose
 
Ja Min Byun
No Relationships to Disclose
 
Christine DiRienzo
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer
 
Andrea Viqueira
Employment - Pfizer
Stock and Other Ownership Interests - Pfizer